Varivax vaccine with diluents
Ended Awarded Last action
- Contract number
- SPE2DR26F98VD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,138
Award facts
- Contract value 100% obligated
- $7,137.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,137.83 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, utilizes firm fixed pricing and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued as a child order under AmerisourceBergen's broader indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through competitive processes and its extensive portfolio of pharmaceutical deliveries position it as a critical vendor for federal medical supply needs within the defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26F98VD?
SPE2DR26F98VD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F98VD worth?
The government has obligated $7,138 on SPE2DR26F98VD.
Is contract SPE2DR26F98VD an order under another contract?
Yes. SPE2DR26F98VD is a delivery order under SPE2DR25D7060, an indefinite delivery contract.
Was contract SPE2DR26F98VD competed?
The extent of competition for SPE2DR26F98VD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award